|
|
courses | hecs/oldps
| higher education home | higher
education links Enabling the Virtuous CycleIdentifying and removing barriers to entrepreneurial activity by health and medical researchers in the higher education sectorExecutive summaryThis study addresses the Wills Review’s finding that there may be institutional barriers to the involvement of university researchers in new business enterprises, specifically in relation to holding equity, directorships and moving between academia and industry. This study finds that policies towards research commercialisation are largely common across Australian universities, and in general, any formal institutional barriers to research commercialisation are few, and in practice can usually be bypassed:
However there are significant variations in the practice of research commercialisation, leading to serious impediments arising from business process inefficiencies in the way in which research commercialisation arrangements operate. A generic business process framework has been developed to provide a basis for universities to analyse their performance, and develop more appropriate approaches. These business process inefficiencies can, to a large extent, be attributed to the relatively recent growth of research commercialisation activity in Australian universities—in other words to a lack of cumulative experience in handling these complex processes. As learning increases, particularly in launching start-up companies, the business process efficiency can be expected to increase, thus adding to the virtuous cycle sought in the Wills Review recommendations. However, this study has revealed that the natural process of learning-by-doing is severely impeded by shortages of funding for ‘proof-of-principle’ and for subsequent investments that produce commercially viable propositions. The government’s announcement of the Biotechnology Innovation Fund specifically targeting the proof-of-principle funding problem in the bio-medical area is therefore an important step forward in enabling the virtuous cycle. The question is whether it needs to be supplemented by alternative schemes such as loans or an overdraft facility that reduce the level of uncertainty over funding for the commercialisation process. In addition, the lack of time available for researchers to engage in research commercialisation is a major constraint. There is a challenge to Government to provide adequate resources to allow this crucial activity to proceed, and to universities to seek to arrange their constrained resources in ways that support those researchers capable and active in research commercialisation. It is difficult to provide an adequate scorecard of Australian university performance in research commercialisation. With regard to start-up companies, it would appear that about one-third of technology start-ups in Australia in 1997 originated directly from universities. The only reliable conclusion is that the rate of formation of technology-based start-up companies arising from university research is increasing. However, assessment of the performance of Australian universities in research commercialisation needs to recognise the very considerable extent of experimentation and change which has occurred over the past 1–2 years. These can be seen as a response to the new conditions of the global knowledge economy, the emergence of global markets for research, the dramatically growing value of technology-based companies, and the greatly increased availability of venture and other forms of capital to invest in research-originated technologies and companies. This experimentation includes:
The outcomes of these various changes are yet to emerge. However, they clearly signal a recognition of the significance of new approaches to research commercialisation. In order to address the issue of best practice, four different configurations of research commercialisation have been identified:
The last of these is seen as particularly appropriate for the Australian situation, in which there is not a strong industry structure with which the universities can interact. Returns from a licensing strategy are ultimately limited by the dearth of potential licensors. Alternatively, a strategy to commercialise through new ventures, while carrying higher risk, offers the possibility of greater long-term returns and the gradual development of a cohort of young science-based firms able to interact far more effectively with the science base—the virtuous cycle in action. Full report PDF
|
|
contact
details | search |
archive search | publications
| site map | subscribe Any comments or queries should be sent to: wwweditor@dest.gov.au This page was
last updated on
Tuesday, 26 August 2008
|